Meihao Medical Group Co (HKSE:01947) Inventories, Raw Materials & Components: HK$3.3 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:01947 Meihao Medical Group Co Ltd HKSE:01947
48 GF Score
Price HK$0.59
GF Value HK$0.40
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Meihao Medical Group Co Inventories, Raw Materials & Components?

Meihao Medical Group Co HKSE:01947 48 Inventories, Raw Materials & Components is HK$3.3 Mil as of Dec. 2025. GuruFocus rates HKSE:01947 with a GF Score™ of 48/100 and a GF Value™ of HK$0.40 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Meihao Medical Group Co's inventories, raw materials & components for the quarter that ended in Dec. 2025 was HK$3.3 Mil.

Meihao Medical Group Co's quarterly raw materials declined from Dec. 2024 (HK$2.5 Mil) to Jun. 2025 (HK$0.0 Mil) but then increased from Jun. 2025 (HK$0.0 Mil) to Dec. 2025 (HK$3.3 Mil).

Meihao Medical Group Co's annual raw materials declined from Dec. 2023 (HK$2.8 Mil) to Dec. 2024 (HK$2.5 Mil) but then increased from Dec. 2024 (HK$2.5 Mil) to Dec. 2025 (HK$3.3 Mil).

Meihao Medical Group Co Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Meihao Medical Group Co's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Meihao Medical Group Co Inventories, Raw Materials & Components Chart

Meihao Medical Group Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Raw Materials & Components
Get a 7-Day Free Trial 2.89 2.80 2.76 2.55 3.27

Meihao Medical Group Co Semi-Annual Data
Dec19 Jun22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Inventories, Raw Materials & Components Get a 7-Day Free Trial 2.76 0.00 2.55 0.00 3.27
HKSE:01947
48GF Score
Meihao Medical Group Co Ltd HKSE:01947
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Meihao Medical Group Co Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of HK$3.3 Mil mean?
Meihao Medical Group Co (HKSE:01947) has a Inventories, Raw Materials & Components of HK$3.3 Mil as of Dec. 2025. Raw materials are the components a company uses for its main products. View historical data on Meihao Medical Group Co and its competitors.
Is Meihao Medical Group Co's Inventories, Raw Materials & Components too high?
Meihao Medical Group Co's current Inventories, Raw Materials & Components is HK$3.3 Mil. Overall, Meihao Medical Group Co has a GF Score™ of 48/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Meihao Medical Group Co's Inventories, Raw Materials & Components compare to HCA and THC?
Meihao Medical Group Co's Inventories, Raw Materials & Components of HK$3.3 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Healthcare Providers & Services company?
A good Inventories, Raw Materials & Components depends on the Healthcare Providers & Services industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Meihao Medical Group Co and its competitors. Meihao Medical Group Co's current Inventories, Raw Materials & Components is HK$3.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Meihao Medical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Meihao Medical Group Co (HKSE:01947) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.40, compared to a current price of HK$0.59 — trading 46.3% above its estimated fair value. The current Inventories, Raw Materials & Components is HK$3.3 Mil. Meihao Medical Group Co's overall GF Score™ is 48/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Meihao Medical Group Co (HKSE:01947), the current Inventories, Raw Materials & Components is HK$3.3 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Meihao Medical Group Co (HKSE:01947) Overvalued in 2026?

Based on GuruFocus' analysis, Meihao Medical Group Co stock appears to be overvalued. The current stock price of HK$0.59 is trading 46.3% above its estimated GF Value™ of HK$0.40. GuruFocus considers Meihao Medical Group Co to be Significantly Overvalued.

Key valuation signals for HKSE:01947:

  • Inventories, Raw Materials & Components: HK$3.3 Mil
  • GF Value™: HK$0.40 vs. price of HK$0.59 (46.3% above fair value)
  • GF Score™: 48/100 with 7 warning signs

No single metric tells the full story. See the HKSE:01947 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Meihao Medical Group Co Business Description

Address 197 Fuqian Street, Lucheng District, Zhejiang Province, Wenzhou, CHN
Meihao Medical Group Co Ltd is a dental service provider in Wenzhou. It offers services to individuals and covers principally four dental sectors: general dentistry, reparative dentistry, implant dentistry, orthodontics, and cosmetic dentistry. The company generates all of its revenue from Mainland China from dental services.
48GF Score

Get the complete analysis for HKSE:01947

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.59
Price
HK$0.40
GF Value